Cite
MLA Citation
Alessandro Isidori et al.. “Real‐life efficacy and safety of idelalisib in 55 double‐refractory follicular lymphoma patients.” British journal of haematology, vol. 199, 2022, pp. 339–343. http://access.bl.uk/ark:/81055/vdc_100168594966.0x000064